Results 11 to 20 of about 249,029 (275)

Clinical impact of vivax malaria: A collection review.

open access: yesPLoS Medicine, 2022
BackgroundPlasmodium vivax infects an estimated 7 million people every year. Previously, vivax malaria was perceived as a benign condition, particularly when compared to falciparum malaria.
Aung Pyae Phyo   +3 more
doaj   +2 more sources

Growing evidence of Plasmodium vivax across malaria-endemic Africa. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2019
Effective malaria control strategies require an accurate understanding of the epidemiology of locally transmitted Plasmodium species. Compared to Plasmodium falciparum infection, Plasmodium vivax has a lower asexual parasitaemia, forms dormant liver ...
Katherine A Twohig   +8 more
doaj   +2 more sources

Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis

open access: yesInfectious Diseases of Poverty, 2018
Background Plasmodium vivax is the most geographically widespread species among human malaria parasites. Immunopathological studies have shown that platelets are an important component of the host innate immune response against malaria infections.
Cho Naing, Maxine A. Whittaker
doaj   +2 more sources

Analysis of Global Research on Malaria and Plasmodium vivax [PDF]

open access: yesInternational Journal of Environmental Research and Public Health, 2019
Background: Malaria is one of the infectious diseases of greatest interest to the scientific community and of greatest concern to international health authorities.
Cebrián Carmona, José   +4 more
core   +3 more sources

The role of cytokines in Plasmodium vivax malaria [PDF]

open access: yesMemórias do Instituto Oswaldo Cruz, 1992
The cytokine tumor necrosis factor and other as yet unidentified factor(s) which together mediate the killing of intraerythrocytic malaria parasites are transiently elevated in sera during paroxysms in human Plasmodium vivax infections in non-immunes.
Mendis, K. N., Carter, R.
openaire   +5 more sources

Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication

open access: yesTropical Diseases, Travel Medicine and Vaccines, 2022
Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P. vivax , however, still presents significant difficulties. This is due to its unique biological traits, which, in comparison to P.
Kassahun Habtamu, B. Petros, G. Yan
semanticscholar   +1 more source

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study

open access: yesPLoS Medicine, 2021
Background A very large biomass of intact asexual-stage malaria parasites accumulates in the spleen of asymptomatic human individuals infected with Plasmodium vivax. The mechanisms underlying this intense tropism are not clear.
Steven Kho   +31 more
semanticscholar   +1 more source

The global burden of Plasmodium vivax malaria is obscure and insidious

open access: yesPLoS Medicine, 2021
J. Kevin Baird and colleagues, examine and discuss the estimated global burden of vivax malaria and it’s biological, clinical, and public health complexity.
K. Battle, J. Baird
semanticscholar   +1 more source

The prevention and treatment of Plasmodium vivax malaria

open access: yesPLoS Medicine, 2021
Cindy S Chu and co-authors review options for diagnosis, safe and radical cure, and relapse prevention of Plasmodium Vivax.
C. Chu, N. White
semanticscholar   +1 more source

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure

open access: yesPLoS Medicine, 2021
In this review for the Vivax malaria collection, Kamala Thriemer and colleagues explore efforts to eliminate P. vivax malaria.
K. Thriemer, B. Ley, L. von Seidlein
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy